6.1 Dose-Response Relationships and Points of Departure

Dose-Response Relationships and Points of Departure

Toxicology is the qualitative and quantitative study of the adverse effects of chemical, biological, and physical agents on living organisms. In industrial hygiene, toxicology provides the scientific bedrock for recognizing chemical hazards, establishing health-protective exposure standards, interpreting biological monitoring data, and designing effective risk management programs. This section reviews fundamental dose-response concepts, quantitative hazard metrics, and the mathematical framework of toxicokinetics—Absorption, Distribution, Metabolism, and Excretion (ADME).

---

1. Foundational Toxicology & Dose-Response Principles

The fundamental axiom of toxicology, first formulated by Paracelsus in the 16th century ("Sola dosis facit venenum" — "Only the dose makes the poison"), states that all substances are toxic at a sufficient dose. In occupational health, the critical distinction lies in the relationship between the internal dose received by a worker and the magnitude or frequency of the resulting biological effect.

Graded vs. Quantal Dose-Response Relationships

1. Graded (Continuous) Dose-Response:

   • Describes the response of an individual organism as the dose increases.
   • The severity of the effect increases continuously with dose (e.g., degree of cholinesterase enzyme inhibition, blood carboxyhemoglobin percentage, or reduction in forced expiratory volume in 1 second, FEV1).
   • Typically plotted as effect magnitude on the y-axis versus log-dose on the x-axis, producing a characteristic hyperbolic or sigmoidal curve.

2. Quantal (All-or-None) Dose-Response:

   • Describes the response of a population of individuals.
   • The response is binary—either an individual exhibits a specific defined effect or does not (e.g., mortality, development of an occupational tumor, sensory irritation threshold).
   • When cumulative percentage response is plotted against log-dose, a symmetrical sigmoidal (S-shaped) curve emerges. When transformed using Probit units (standard normal deviations + 5 to avoid negative numbers), the sigmoidal curve linearizes, enabling precise statistical regression for median response doses.

   +-------------------------------------------------------------+
   |               DOSE-RESPONSE CURVE ARCHETYPES                |
   +-------------------------------------------------------------+
   |  % Response                                                 |
   |  100 |                     /--- Non-Carcinogen / Threshold  |
   |      |                    /                                 |
   |   50 |                   /   /-- Genotoxic Carcinogen (LNT) |
   |      |                  /   /                               |
   |    0 +-----------------/---/------------------------>       |
   |      0             Threshold      Dose (Log Scale)          |
   +-------------------------------------------------------------+

Threshold vs. Non-Threshold (LNT) Concepts

• Threshold Toxicants (Non-Carcinogens & Non-Genotoxic Endpoints):

  • Biological premise: Organisms possess homeostatic defense mechanisms, reserve cellular capacity, DNA repair enzymes, and metabolic detoxification pathways that neutralize toxicants at low doses.
  • An adverse biological response occurs only after these physiological defense reserves are overwhelmed.
  • Below the threshold dose, the probability of the adverse effect is virtually zero. Occupational Exposure Limits (OELs, TLVs, PELs) for systemic toxicants and organ toxins are derived based on threshold concepts.

• Non-Threshold / Linear No-Threshold (LNT) Toxicants (Genotoxic Carcinogens & Ionizing Radiation):

  • Biological premise: A single molecule of an electrophilic chemical mutagen or a single ionizing track can interact directly with nuclear DNA, inducing an unrepaired somatic mutation in a proto-oncogene or tumor suppressor gene that can initiate neoplastic clonal expansion.
  • Theoretically, no safe dose exists; any exposure above zero carries a finite, non-zero probability of inducing cancer.
  • Regulatory bodies (OSHA, EPA, NIOSH) evaluate carcinogens using linearized multistage models, expressing risks as excess cancer incidence per unit exposure (e.g., 10⁻⁴ or 10⁻⁶ lifetime risk).

---

2. Points of Departure and Quantitative Hazard Metrics

In toxicological risk assessment, experimental animal and human epidemiological data are evaluated to identify a Point of Departure (POD)—the toxicological dose benchmark used to extrapolate safe occupational exposure boundaries.

   +-------------------------------------------------------------+
   |                POINTS OF DEPARTURE ON A CURVE               |
   +-------------------------------------------------------------+
   |  Response (%)                                               |
   |    ^                                                        |
   |    |                                  *  High Adverse Effect|
   |    |                          *                             |
   |    |                   *  LOAEL (First significant effect)  |
   | 10 |-------------*  BMDL10 (95% Lower confidence on BMD)    |
   |    |          *  NOAEL (No statistically significant effect)|
   |  0 +----------+-----+----------------------------------->   |
   |              NOAEL LOAEL                 Dose (mg/kg/day)   |
   +-------------------------------------------------------------+

Definitions of Core Toxicological Points of Departure

Uncertainty Factors (UFs) in Setting Exposure Limits

When deriving acceptable human exposure metrics—such as an EPA Reference Dose (RfD), an ACGIH TLV, or an occupational target limit—from an animal or subchronic study, safety/uncertainty factors are applied multiplicatively:

$RfD = \frac{\text{POD (NOAEL or } \text{BMDL}_{10}\text{)}}{\prod \text{UF}} = \frac{\text{NOAEL}}{UF_A \times UF_H \times UF_S \times UF_L \times UF_D}$

• UFA (Interspecies Extrapolation, 10×): Accounts for pharmacokinetic and pharmacodynamic differences between experimental animals and humans.
• UFH (Intraspecies / Human Variability, 10×): Accounts for genetic polymorphisms, age, pre-existing disease, and nutritional variance within human populations.
• UFS (Subchronic to Chronic Duration, 10×): Applied when only a 90-day subchronic study is available to predict lifetime chronic occupational exposure.
• UFL (LOAEL to NOAEL Extrapolation, 10×): Applied when a true NOAEL was not established in the study and extrapolation starts from a LOAEL.
• UFD (Database Incompleteness, 3× to 10×): Applied when essential reproductive, developmental, or chronic toxicity data are missing.

Acute Lethality Indices: LD50, LC50, and Haber's Rule

• LD50 (Median Lethal Dose): The statistically calculated dose of a chemical required to kill 50% of an animal test population under specified experimental conditions, expressed in milligrams of toxicant per kilogram of body weight (extmg/kg).
• LC50 (Median Lethal Concentration): The statistically calculated concentration of a vapor, gas, or airborne particulate in air required to kill 50% of a test population over a specified exposure duration (e.g., 4-hour LC50), expressed in ppm or mg/m³.

Haber's Rule of Inhalation Toxicity

For acute, cumulative chemical exposures, Haber's Rule states that the product of exposure concentration (C) and duration (t) produces a constant biological effect (k):

$C \times t = k$

Limitation: Haber's rule fails for rapidly detoxified substances (where detoxification rate prevents accumulation at low concentrations over long durations) and sensory irritants (where effect depends on instantaneous peak concentration rather than integrated time-dose product).

Therapeutic Index vs. Margin of Safety

In classical pharmacology and industrial toxicology, relative safety is evaluated by comparing the lethal dose curve with the effective/toxic threshold curve:

$\text{Therapeutic Index (TI)} = \frac{\text{LD}_{50}}{\text{ED}_{50}}$

$\mathbf{\text{Margin of Safety (MOS)} = \frac{\text{LD}_{01}}{\text{ED}_{99}}}$

Exam Key Concept: The Therapeutic Index (TI) can be misleading because it only compares median points (extLD50 and extED50) and ignores curve slopes. If two chemicals have identical median ratios but different dose-response slopes, the one with a flatter lethal slope may produce lethal fatalities at doses within the "effective" range. The Margin of Safety (MOS) compares the 1% lethal threshold (LD01) to the 99% effective threshold (ED99), providing a rigorous assessment of overlapping toxicity.

---